BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

156 related articles for article (PubMed ID: 32044726)

  • 1. miR-552 Regulates Liver Tumor-Initiating Cell Expansion and Sorafenib Resistance.
    Han T; Zhang Y; Yang X; Han L; Li H; Chen T; Zheng Z
    Mol Ther Nucleic Acids; 2020 Mar; 19():1073-1085. PubMed ID: 32044726
    [TBL] [Abstract][Full Text] [Related]  

  • 2. miR-96 regulates liver tumor-initiating cells expansion by targeting TP53INP1 and predicts Sorafenib resistance.
    Huang Y; Zhang J; Li H; Peng H; Gu M; Wang H
    J Cancer; 2020; 11(22):6545-6555. PubMed ID: 33046975
    [TBL] [Abstract][Full Text] [Related]  

  • 3. microRNA-29a regulates liver tumor-initiating cells expansion via Bcl-2 pathway.
    Song S; Sun K; Dong J; Zhao Y; Liu F; Liu H; Sha Z; Mao J; Ding G; Guo W; Fu Z
    Exp Cell Res; 2020 Feb; 387(2):111781. PubMed ID: 31857112
    [TBL] [Abstract][Full Text] [Related]  

  • 4. microRNA-454 promotes liver tumor-initiating cell expansion by regulating SOCS6.
    Lei Z; Tang X; Si A; Yang P; Wang L; Luo T; Guo G; Zhang Q; Cheng Z
    Exp Cell Res; 2020 May; 390(1):111955. PubMed ID: 32165166
    [TBL] [Abstract][Full Text] [Related]  

  • 5. miR-361-3p Regulates Liver Tumor-initiating Cells Expansion and Chemo-resistance.
    Qu S; Zhang X; Wu Y; Li H; Zhai J; Wu D
    J Cancer; 2021; 12(5):1483-1492. PubMed ID: 33531993
    [TBL] [Abstract][Full Text] [Related]  

  • 6. miR-124 regulates liver cancer stem cells expansion and sorafenib resistance.
    Feng Y; Jiang W; Zhao W; Lu Z; Gu Y; Dong Y
    Exp Cell Res; 2020 Sep; 394(2):112162. PubMed ID: 32640195
    [TBL] [Abstract][Full Text] [Related]  

  • 7. MicroRNA-28-5p Regulates Liver Cancer Stem Cell Expansion via IGF-1 Pathway.
    Xia Q; Han T; Yang P; Wang R; Li H; Zhang J; Zhou X
    Stem Cells Int; 2019; 2019():8734362. PubMed ID: 31885628
    [TBL] [Abstract][Full Text] [Related]  

  • 8. miR-4461 Inhibits Liver Cancer Stem Cells Expansion and Chemoresistance via Regulating SIRT1.
    Yang D; Zhang P; Yang Z; Hou G; Yang Z
    Carcinogenesis; 2022 Nov; ():. PubMed ID: 36437743
    [TBL] [Abstract][Full Text] [Related]  

  • 9. miR-93 regulates liver tumor initiating cells expansion and predicts chemotherapeutic response of patients.
    Li J; Zhong X; Wang X; Xu F; Yang J; Lu J; Liu C; Lu J
    Arch Biochem Biophys; 2021 May; 703():108871. PubMed ID: 33831356
    [TBL] [Abstract][Full Text] [Related]  

  • 10. MiR-21 mediates sorafenib resistance of hepatocellular carcinoma cells by inhibiting autophagy via the PTEN/Akt pathway.
    He C; Dong X; Zhai B; Jiang X; Dong D; Li B; Jiang H; Xu S; Sun X
    Oncotarget; 2015 Oct; 6(30):28867-81. PubMed ID: 26311740
    [TBL] [Abstract][Full Text] [Related]  

  • 11. miR-186 Inhibits Liver Cancer Stem Cells Expansion
    Yao H; Yang Z; Lou Y; Huang J; Yang P; Jiang W; Chen S
    Front Oncol; 2021; 11():632976. PubMed ID: 33816273
    [TBL] [Abstract][Full Text] [Related]  

  • 12. MicroRNA-216a/217-induced epithelial-mesenchymal transition targets PTEN and SMAD7 to promote drug resistance and recurrence of liver cancer.
    Xia H; Ooi LL; Hui KM
    Hepatology; 2013 Aug; 58(2):629-41. PubMed ID: 23471579
    [TBL] [Abstract][Full Text] [Related]  

  • 13. miR-613 inhibits liver cancer stem cell expansion by regulating SOX9 pathway.
    Li B; Liu D; Yang P; Li HY; Wang D
    Gene; 2019 Jul; 707():78-85. PubMed ID: 31075412
    [TBL] [Abstract][Full Text] [Related]  

  • 14. MicroRNA-519a promotes tumor growth by targeting PTEN/PI3K/AKT signaling in hepatocellular carcinoma.
    Tu K; Liu Z; Yao B; Han S; Yang W
    Int J Oncol; 2016 Mar; 48(3):965-74. PubMed ID: 26708293
    [TBL] [Abstract][Full Text] [Related]  

  • 15. MiR-128-3p overexpression sensitizes hepatocellular carcinoma cells to sorafenib induced apoptosis through regulating DJ-1.
    Guo XL; Wang HB; Yong JK; Zhong J; Li QH
    Eur Rev Med Pharmacol Sci; 2018 Oct; 22(20):6667-6677. PubMed ID: 30402839
    [TBL] [Abstract][Full Text] [Related]  

  • 16. NRF2/SHH signaling cascade promotes tumor-initiating cell lineage and drug resistance in hepatocellular carcinoma.
    Leung HW; Lau EYT; Leung CON; Lei MML; Mok EHK; Ma VWS; Cho WCS; Ng IOL; Yun JP; Cai SH; Yu HJ; Ma S; Lee TKW
    Cancer Lett; 2020 Apr; 476():48-56. PubMed ID: 32061952
    [TBL] [Abstract][Full Text] [Related]  

  • 17. miR-194 inhibits liver cancer stem cell expansion by regulating RAC1 pathway.
    Ran RZ; Chen J; Cui LJ; Lin XL; Fan MM; Cong ZZ; Zhang H; Tan WF; Zhang GQ; Zhang YJ
    Exp Cell Res; 2019 May; 378(1):66-75. PubMed ID: 30844391
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Exosomal MiR-744 Inhibits Proliferation and Sorafenib Chemoresistance in Hepatocellular Carcinoma by Targeting PAX2.
    Wang G; Zhao W; Wang H; Qiu G; Jiang Z; Wei G; Li X
    Med Sci Monit; 2019 Sep; 25():7209-7217. PubMed ID: 31553714
    [TBL] [Abstract][Full Text] [Related]  

  • 19. microRNA-19a-3p promotes tumor metastasis and chemoresistance through the PTEN/Akt pathway in hepatocellular carcinoma.
    Jiang XM; Yu XN; Liu TT; Zhu HR; Shi X; Bilegsaikhan E; Guo HY; Song GQ; Weng SQ; Huang XX; Dong L; Janssen HLA; Shen XZ; Zhu JM
    Biomed Pharmacother; 2018 Sep; 105():1147-1154. PubMed ID: 30021351
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Hepatic transforming growth factor beta gives rise to tumor-initiating cells and promotes liver cancer development.
    Wu K; Ding J; Chen C; Sun W; Ning BF; Wen W; Huang L; Han T; Yang W; Wang C; Li Z; Wu MC; Feng GS; Xie WF; Wang HY
    Hepatology; 2012 Dec; 56(6):2255-67. PubMed ID: 22898879
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.